Literature DB >> 24476450

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.

Paul S Giacomini1, Ayal Rozenberg, Imke Metz, David Araujo, Nathalie Arbour, Amit Bar-Or.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24476450      PMCID： PMC5052063          DOI： 10.1056/NEJMc1304828

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

Authors:  I L Tan; J C McArthur; D B Clifford; E O Major; A Nath
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

2.  Immunological and clinical consequences of treating a patient with natalizumab.

Authors:  Nicholas Schwab; Karin G Höhn; Tilman Schneider-Hohendorf; Imke Metz; Max-Philipp Stenner; Samantha Jilek; Renaud A Du Pasquier; Ralf Gold; Sven G Meuth; Richard M Ransohoff; Wolfgang Brück; Heinz Wiendl
Journal:  Mult Scler       Date:  2011-09-09       Impact factor: 6.312

3.  JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Eleonora Tavazzi; Enrico Marchioni; Silvia Carluccio; Lucia Signorini; Stefano Novati; Renato Maserati; Pasquale Ferrante
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

4.  Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Tarek A Yousry; Daniel Pelletier; Diego Cadavid; Achim Gass; Nancy D Richert; Ernst-Wilhelm Radue; Massimo Filippi
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

5.  Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?

Authors:  Caroline Antoniol; Samantha Jilek; Myriam Schluep; Noëlle Mercier; Mathieu Canales; Géraldine Le Goff; Claudia Campiche; Giuseppe Pantaleo; Renaud A Du Pasquier
Journal:  Neurology       Date:  2012-11-21       Impact factor: 9.910
  5 in total
  37 in total

Review 1.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

2.  Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment.

Authors:  C C Chang; V Sheikh; I Sereti; M A French
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

3.  Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.

Authors:  Alex Ganetsky; Todd A Miano; Mitchell E Hughes; Robert H Vonderheide; David L Porter; Ran Reshef
Journal:  J Antimicrob Chemother       Date:  2015-04-16       Impact factor: 5.790

Review 4.  Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.

Authors:  Emanuele D'Amico; Aurora Zanghì; Carmela Leone; Hayrettin Tumani; Francesco Patti
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

Review 5.  Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.

Authors:  Lokesh Shahani; Minal Shah; Shahriar Tavakoli-Tabasi
Journal:  BMJ Case Rep       Date:  2015-06-10

Review 6.  [Progressive multifocal leukoencephalopathy].

Authors:  C Warnke; M P Wattjes; O Adams; H-P Hartung; R Martin; T Weber; M Stangel
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

7.  [Immune reconstitution inflammatory syndrome after cessation of immunosuppressive therapy].

Authors:  B Ehrenstein
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

Review 8.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

9.  Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.

Authors:  Nathan A Summers; Colleen F Kelley; Wendy Armstrong; Vincent C Marconi; Minh Ly Nguyen
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-03       Impact factor: 2.205

10.  JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.

Authors:  Shruti P Agnihotri; Xin Dang; Jonathan L Carter; Terry D Fife; Evelyn Bord; Stephanie Batson; Igor J Koralnik
Journal:  Neurology       Date:  2014-07-18       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.